HAVCR2 and neoplasm: T-cell immunoglobulin and mucin domain 3 (TIM-3) is an immunomodulatory receptor that binds to ligands on tumor cells and the microenvironment and inhibits antitumor immunity in a variety of cancers, including HCC.